SCHEMBL25675697

SCHEMBL25675697

Cc1cc(C(C)(C)C)ccc1N1CC2(CNC2)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
KDM4E B2RXH2 2/20 0.35
LRRK2 Q5S007 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HSD11B1 P28845 1/20 0.33
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
ADRA1D P25100 1/20 0.32
HTR1D P28221 1/20 0.32
HTR1B P28222 1/20 0.32
ADRA1A P35348 1/20 0.32
ADRA1B P35368 1/20 0.32
KCNH2 Q12809 1/20 0.32
SCN10A Q9Y5Y9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24123837 0.86 HTR3A (0.40) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL25675715 0.85 NPY2R (0.36) HTR3AKDM4EHSD11B1ALDH1A1MAPT
SCHEMBL25675695 0.85 KIF11 (0.33) HSD11B1KCNH2SCN10AKIF11HRH4
SCHEMBL25675696 0.83 KDM4E (0.35) KDM4ELRRK2MEN1KMT2AHSD11B1
SCHEMBL25675711 0.82 DDB1 (0.37) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL25675705 0.79 KIF11 (0.33) KIF11TSHR
SCHEMBL25675699 0.77 TSHR (0.40) KDM4EHSD11B1ALDH1A1MAPTHRH3
SCHEMBL24123591 0.76 HTR3A (0.59) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL24123858 0.75 DRD2 (0.48) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL25675736 0.75 LRRK2 (0.38) KDM4ELRRK2MEN1KMT2AHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159540-A1 PYRAZOLO[3,4-d]PYRIMIDIN-3-ONE DERIVATIVE AS WEE-1 INHIBITOR PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE DERIVATIVE AS WEE-1 INHIBITOR (CN) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159540-A1 PYRAZOLO[3,4-d]PYRIMIDIN-3-ONE DERIVATIVE AS WEE-1 INHIBITOR WEE1, WEE2, PEAK1 HTR3E 2816/4885HTR3B 4548/4885HTR3A 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.